New aspects of human trichinellosis: the impact of new Trichinella species
- 1Department of Experimental Pathology, University of Pisa, Pisa, Italy
- 2Danish Center for Experimental Parasitology, Royal Veterinary and Agricultural University, Frederiksberg, Denmark
- Correspondence to: Dr Fabrizio Bruschi, Dipartimento di Patologia Sperimentale, BMIE, Università di Pisa, Via Roma, 55, Pisa, Italy; fbruschi{at}med.unipi.it
- Received 22 March 2001
- Accepted 24 July 2001
Abstract
Trichinellosis is a re-emerging zoonosis and more clinical awareness is needed. In particular, the description of new Trichinella species such as T papuae and T murrelli and the occurrence of human cases caused by T pseudospiralis, until very recently thought to occur only in animals, requires changes in our handling of clinical trichinellosis, because existing knowledge is based mostly on cases due to classical T spiralis infection. The aim of the present review is to integrate the experiences derived from different outbreaks around the world, caused by different Trichinella species, in order to provide a more comprehensive approach to diagnosis and treatment.
- ADCC, antibody dependent cellular cytotoxicity
- CPK, creatine phosphokinase
- ELISA, enzyme linked immunosorbent assay
- IL-5, interleukin-5
- LDH, lactate dehydrogenase







